Propanc Biopharma Submits Orphan Drug Designation Request to the US Food and Drug Administration for Treatment of Ovarian Cancer
MELBOURNE, AUSTRALIA--(Marketwired - October 25, 2017) - Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or "the Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments …